EUVIMEDEUVIMED entdecken
Open Access

Positron emission tomography-magnetic resonance imaging applications in pediatric musculoskeletal tumors

Isabel Plaza de Las Heras iD, Lina García Cañamaque, Elena Quílez Caballero, Mónica Camacho-Arias, María Del Pilar Cárdenas Soriano, José Martel Villagrán

Quantitative Imaging in Medicine and Surgery · 2024-11 · 14 (11) · 7825-7838

DOI: 10.21037/qims-24-621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quantitative Imaging in Medicine and Surgery, 2024-11. Verfasst von Isabel Plaza de Las Heras und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, Alcorcon Foundation University Hospital, Alcorcon, Madrid, Spain. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The hybrid imaging positron emission tomography/magnetic resonance (PET/MR) is an important tool in the management of pediatric oncology patients, particularly in malignant musculoskeletal pathologies, because it combines the functional and metabolic information of tumor provided by PET with the high soft-tissue contrast and the functional information offered by magnetic resonance imaging (MRI).

Methods

We performed an observational retrospective study that included pediatric patients diagnosed with primary bone or soft-tissue sarcomas in the Pediatric Hematology and Oncology Unit at the HM Montepríncipe University Hospital, Boadilla del Monte, Madrid (Spain) who underwent whole-body 18F-fluorodeoxyglucose (18F-FDG) PET/MRI as a staging study and for follow-up evaluation for treatment response from September 2017 to January 2023. This study explores the protocols, the practical application of the PET/MRI technique and our clinical experience at our center in the diagnosis and follow-up of primary bone tumors and soft-tissue sarcomas in children.

Results

Seventy-one 18F-PET/MR studies were performed on 39 patients. Most of them (55%) were initial extension studies and (45%) were follow-up studies. Most of the patients studied were male (74.4%) with a median age of 15 years. Of the 39 cases, 51% were primary bone tumors while 18% were Langerhans cell histiocytosis and 21% soft tissue tumors. Of the 71 studies, five showed metastases at the initial diagnosis, three presented lymph node involvement, one with local infiltration, and one with pulmonary metastasis.

Conclusions

PET/MR has represented a significant advancement in the evaluation of pediatric malignant neoplasms, with specific applications in musculoskeletal tumors showing clear benefits over PET/CT. The primary advantage is the reduction in ionizing radiation doses and the assessment of soft tissues, making it an excellent option for malignant musculoskeletal pathologies in pediatric patients who often require long-term follow-up. It is particularly useful for early tumor detection and functional therapy monitoring in oncology. The development of new protocols is making studies increasingly faster and better tolerated, even without the need for anesthesia. PET/MRI has shown to increase diagnostic accuracy in primary bone and soft tissue tumors, as it allows for the comprehensive evaluation of their morpho-metabolic characteristics, locoregional, and distant involvement in a single study. It is also useful in surgical planning and post-treatment follow-up.

Schlagwörter

Stichwörter der Autor:innen

Magnetic resonance imaging (MRI)bone sarcomapediatric cancerpositron emission tomography (PET)positron emission tomography/magnetic resonance (PET/MR)

Autor:innen und Institutionen

  • Nuclear Medicine Unit, Alcorcon Foundation University Hospital, Alcorcon, Madrid, Spain.
  • Pediatric Hematology and Oncology Unit, HM Monteprincipe University Hospital, Boadilla del Monte, Madrid, Spain.
  • Preventive Medicine Unit, Alcorcon Foundation University Hospital, Alcorcon, Madrid Spain.
  • Escuela Internacional de Doctorado, Rey Juan Carlos University, Madrid, Spain.
  • Radiology Unit, Alcorcon Foundation University Hospital, Alcorcon, Madrid, Spain.

ORCID-Profile: Isabel Plaza de Las Heras

Zitieren

APA

Plaza de Las Heras, I., García Cañamaque, L., Quílez Caballero, E., Camacho-Arias, M., Cárdenas Soriano, M. D. P., & Martel Villagrán, J. (2024). Positron emission tomography-magnetic resonance imaging applications in pediatric musculoskeletal tumors. Quantitative Imaging in Medicine and Surgery, 14(11), 7825-7838. https://doi.org/10.21037/qims-24-621

Vancouver

Plaza de Las Heras I, García Cañamaque L, Quílez Caballero E, Camacho-Arias M, Cárdenas Soriano MDP, Martel Villagrán J. Positron emission tomography-magnetic resonance imaging applications in pediatric musculoskeletal tumors. Quantitative Imaging in Medicine and Surgery. 2024;14(11):7825-7838. doi:10.21037/qims-24-621

BibTeX
@article{PlazadeLasHeras2024,
  author = {Plaza de Las Heras, Isabel and García Cañamaque, Lina and Quílez Caballero, Elena and Camacho-Arias, Mónica and Cárdenas Soriano, María Del Pilar and Martel Villagrán, José},
  title = {Positron emission tomography-magnetic resonance imaging applications in pediatric musculoskeletal tumors},
  journal = {Quantitative Imaging in Medicine and Surgery},
  year = {2024},
  volume = {14},
  number = {11},
  pages = {7825--7838},
  doi = {10.21037/qims-24-621}
}
Kostenlos starten →